Cardiotoxicity Within Cardio-Oncology: Clinical Advances from Prediction to Management

Dear Colleagues,

The field of cardio-oncology has undergone remarkable expansion in recent years, reflecting the growing need to address cardiovascular complications associated with modern cancer therapies. Cardiotoxicity, in its various forms, remains a significant barrier to optimal oncological outcomes and long-term survivorship. Advances in risk prediction, ranging from circulating biomarkers to genetic profiling and refined imaging modalities, have paved the way for earlier detection of subclinical cardiac dysfunction. At the same time, structured surveillance algorithms and preventive strategies are increasingly integrated into clinical pathways. From a therapeutic perspective, the implementation of cardioprotective regimens, optimization of heart failure therapies, and multidisciplinary management approaches have redefined standards of care. This Special Issue, “Cardiotoxicity Within Cardio-Oncology: Clinical Advances from Prediction to Management”, seeks to highlight clinical and translational progress in this rapidly evolving field. We welcome submissions focusing on novel diagnostic strategies, risk stratification tools, therapeutic interventions, organization of Cardio-Oncology Units and long-term outcomes in cancer patients at risk for, or affected by, cardiotoxicity.

Dr. Massimiliano Camilli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.